HomeProductsBioactive CompoundsApoptosisc-RETEnmd-2076
Chemical structure of CAS 934353-76-1

Enmd-2076

CAS No.934353-76-1
MDL No.MFCD16619371
MFC21H25N7
MW375.50
InChI KeyBLQYVHBZHAISJM-CMDGGOBGSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.934353-76-1
Product NameEnmd-2076

Biological Targets

FGFR3·CSF1R·AURKA·AURKB·KIT·

Associated Conditions

lymphoid neoplasm·cancer·clear cell adenocarcinoma·soft tissue sarcoma·peritoneum cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Discovery and development of aurora kinase inhibitors as anticancer agents.

Journal of medicinal chemistry • Vol. 52, Issue 9 • 2009
PMID: 19320489DOI: 10.1021/jm8012129

Documentation